Drug Trial Radar · NCT07783308
A Phase I Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD4144
Last checked: Nov 19, 2026Latest source record: Aug 24, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
30
Planned (sponsor's estimate)
Start
Aug 24, 2026
Primary completion
May 28, 2027
Study completion May 28, 2027
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- First posted
- Aug 24, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This Phase I, open-label, parallel group study will investigate the single oral dose PK, safety, and tolerability of AZD4144 to male and female participants with mild, moderate, and severe hepatic impairment compared to matched controls with normal hepatic function.
Conditions
- Hepatic Impairment
Interventions
AZD4144Drug
Single oral dose of AZD4144 in participants from all groups
Primary outcomes
What the sponsor says the trial is designed to measure.
- PK parameters AUCinfTime frame: Day 0 through Day 7 or 9
- PK parameter AUClastTime frame: Day 0 through Day 7 or 9
- PK parameters AUC(0-144)Time frame: Day 0 through Day 7
- PK parameter CmaxTime frame: Day 0 through Day 7 or 9
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Research Site
Mesa, Arizona
Research Site
Miami Lakes, Florida
Research Site
Orlando, Florida
Research Site
Austin, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.